SES S. A. (SESG)
Euronext Paris · France · prices in EUR · close of 19 Oct 2026
Key indicators
| Last close | EUR 4.164 |
|---|---|
| 52-week range | 3.506 – 9.250 |
| Return, 1 month / 3 months | −6.4% / −39.8% |
| Return, 1 year / 3 years | −26.8% / +7.1% |
| Trend | Below its 200-day average |
| RSI (14) | 53 |
| Volatility (1 year) | 51.2% |
| Worst drawdown (1 year) | -62.1% |
| Average daily value traded | 5.26M EUR |
| Dividend yield | 12.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
SES is a satellite communications company based in Luxembourg. It operates a fleet of satellites in geostationary and medium earth orbit and uses them to provide connectivity and broadcasting services. Its customers include broadcasters, telecommunications operators, governments and enterprises, which rely on the company for television distribution, broadband connectivity and data networking across many regions of the world.
SES S. A. trades under the code SESG on the Euronext Paris in France, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
SES S. A. (SESG) trades on the Euronext Paris in France. It last closed at EUR 4.164 on 19 October 2026.
Its price-based Market X-Ray is 35 out of 100 (a weak price profile), ranking 466 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 26.8% and over the last three months it fell 39.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 13 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -29.5% | ||
| From 52-week high | -55.0% | ||
| Momentum | 17 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -39.8% | ||
| 6-month return | -33.9% | ||
| 12-month return, skipping the last month | -21.8% | ||
| Stability (higher is calmer) | 28 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 51.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -62.1% | ||
| Liquidity | 88 · Strong | Trades actively. | |
| Average daily value traded | 5.26M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 77 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 12.0% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +15.2% |
|---|---|
| 1 month | −6.4% |
| 3 months | −39.8% |
| 6 months | −33.9% |
| 1 year | −26.8% |
| 3 years | +7.1% |
| 5 years | −5.0% |
Signals
| 50-day / 200-day average | 4.357 / 5.904 |
|---|---|
| Golden / death cross (60 days) | Death, 35 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.191 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 13 Oct 2026 | EUR 0.2500 |
| 14 Apr 2026 | EUR 0.2500 |
| 14 Oct 2025 | EUR 0.2500 |
| 15 Apr 2025 | EUR 0.2500 |
| 15 Oct 2024 | EUR 0.2500 |
| 16 Apr 2024 | EUR 0.5000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.